Dra. Núria Almiñana Domènech

Institutions of which it is part

I have a PhD in Pharmacy and a degree in Biochemistry. My expertise focuses on the field of skin biology, both as a researcher in basic and clinical research, as well as in the field of research project management. After developing my career in the private sector, I want to continue my professional growth and development in the field of innovation management in the health sector. I am currently working in the Scientific Strategy Unit of VHIR, as Project Manager for eCOREs.


I have more than 18 years of expertise dedicated to the world of scientific research in the field of Cell Biology and Biotechnology sector.

Once I finished my degrees in Pharmacy and Biochemistry, I obtained a grant from the Spanish Government to do an Industrial PhD in collaboration with CSIC (Superior Council of Scientific Investigations) and a company, Lipotec S.A., a young Catalan small company dedicated to several fields, including Pharma, Nutrition and Cosmetics.

During my PhD, I worked on a project related to the Pharma area of the company, developing new delivery systems to target tumoral cells, based on Doxorubicin liposomes coated with extracellular matrix synthetic peptides. Thanks to the work done during my PhD, I was able to develop my technical skills on liposome preparation, peptide synthesis, cell culture techniques, screening of antitumor and antiangiogenic drugs, fluorescence techniques, HPLC, physicochemical studies and microscopy (including bright field, fluorescence and electron microscopy).

After finishing my PhD, in 2004, I had the opportunity to join the company as a Biochemist Specialist for the Cosmetics area, and I took advantage of all the knowledge I acquired during my academic experience to introduce biological and biochemical know-how in the company. I was responsible for designing, implementing and managing a new cell culture laboratory that allowed integrating in house a new technology based on the use of human skin cells to setup and optimize new cost-effective cell culture methods that comprise both in vitro (enzymatic assays and 2D cell cultures) and also ex vivo (3D cultures, including skin biopsies and reconstructed skin models), to develop new active ingredients, including synthetic peptides, biotechnological extracts and botanicals for skin care.

Since 2008, I was also involved in the design and execution of in clinical studies and thanks to my education as a Pharmacist, I adapted my knowledge related to pharmaceutical clinical studies to the cosmetic field. After some years of working with external CROs, in 2015, I was responsible for implementing another new laboratory in the company based on clinical testing.

After several years dedicated directly to the experimental work, since 2010, I focused on my role as department manager, supervising the scientific research led by several Project Leaders and performed by laboratory technicians, being my main functions scientific direction, project and team management, and translating science into new products.
Núria Almiñana Domènech


Vall Hebron Institut de Recerca

Tècnic/a Grau Superior

Technical Secretary

Internal Strategy Directorate

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.